* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.
Quinolinate is an intermediate in the ab initio synthesis of NAD from tryptophan and acts as an effective endogenous excitotoxin by over-stimulating the receptor of N-methyl D-aspartate (NMDA) in neurons. It has been speculated that the increase of quinolinate level in human brain is related to the pathogenesis of neurodegenerative diseases. Mammalian quinoline ester phosphoribosyltransferase (QPRTase) is a key enzyme in the catabolism of quinoline esters. Quinolinate is the most effective endogenous toxin in neurons. Increased levels of quinolinic acid in the brain are associated with the pathogenesis of neurodegenerative diseases such as epilepsy, Alzheimer's disease and Huntington's disease.
|Cat.No.||Product Name||Source||Species||Tag||Molecular Weight|
|BP-801535||Recombinant Mouse QPRT Protein||Mammalian Cells||Mouse||His|
|BP-801536||Recombinant Human Quinolinate Phosphoribosyltransferase, His-tagged||E.coli.|
|BP-801537||Recombinant Human QPRT, T7-tagged||E.coli.|
|BP-801538||Recombinant Human QPRT, T7 -tagged||E. coli|
|BP-801539||Recombinant Human QPRT, His-tagged||E. coli|
|BP-801540||Recombinant Rat QPRT Protein||Mammalian Cells||Rat||His|
* PROTAC® is a registered trademark of Arvinas Operations, Inc., and is used under license.
Please contact us with any specific requirements and we will get back to you as soon as possible.